logo

Achillion Pharmaceuticals Inc. (ACHN)



Trade ACHN now with
  Date
  Headline
12/19/2019 10:16:23 AM Achillion Shareholders Ok Agreement To Be Acquired By Alexion
12/19/2019 9:27:37 AM Achillion Shareholders Approve Agreement To Be Bought By Alexion
11/19/2019 7:37:20 AM Achillion: EMA Grants Access To Support Through PRIME Program For Danicopan
10/16/2019 6:33:14 AM Alexion To Acquire Achillion For Initial All-cash Transaction For $6.30/Shr
9/25/2019 7:08:28 AM Achillion Says FDA Granted Breakthrough Therapy Designation For Danicopan
7/22/2019 7:10:40 AM Achillion’s ACH-5228 Achieves Positive Results In Phase 1 Multiple Ascending Dose Study In Healthy Volunteers
4/3/2019 6:06:55 AM Achillion Achieves Threshold Enrollment In Phase 2 Trials Of ACH-4471 For Patients With C3 Glomerulopathy
3/27/2019 6:20:47 AM Achillion Completes Enrollment In ACH-4471 Phase 2 PNH Trial In Combination With Eculizumab
3/7/2019 6:05:57 AM Achillion Pharma Q4 Net Loss $16.6 Mln Vs Loss Of $23.2 Mln Last Year
2/11/2019 6:15:06 AM Achillion Appoints Brian Di Donato SVP And CFO
1/31/2019 6:06:57 AM Achillion Reports First Dosing In Phase 1 Multiple Ascending Dose Study Of ACH-5228
1/3/2019 6:01:45 AM Achillion Names Nicole Vitullo To Chair The Board
11/7/2018 6:12:05 AM Achillion Q3 Net Loss $15.9 Mln Vs Net Loss $19.3 Mln Last Year
9/10/2018 6:00:42 AM Achillion Appoints Paul Firuta To EVP And COO
  
 
>